Rocket Pharmaceuticals News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

28.06.24	Rocket Pharma Receives FDA's Complete Response Letter For Kresladi (RTTNews)
29.05.24	Rocket Pharma Says EC Granted Orphan Medicinal Product Designation For RP-A601 (RTTNews)
26.03.24	Rocket Pharmaceuticals Names Aaron Ondrey CFO (RTTNews)
13.02.24	Rocket Pharma Says FDA Extends Review Timeline For BLA For Kresladi For LAD-1 (RTTNews)
02.10.23	Rocket Pharmaceuticals: FDA Grants Priority Review For RP-L201 - Quick Facts (RTTNews)
13.09.23	Pre-market Movers: GDHG, SNTG, DMS, MYNZ, RCKT… (RTTNews)
08.06.23	Rocket Pharma Says FDA Grants Fast Track And Orphan Drug Designations For RP-A601 Gene Therapy (RTTNews)
31.05.23	Rocket Pharma Says EMA Grants PRIME Designation For RP-A501 Gene Therapy For Danon Disease (RTTNews)
04.05.23	Rocket Pharmaceuticals, Inc. Q1 Loss increases, but beats estimates (RTTNews)
07.02.23	Rocket Gets RMAT Designation From FDA For RP-A501 Therapy Targeting Danon Disease (RTTNews)
16.11.22	SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SBCF, RCKT, CLR, USER (PR Newswire)
10.11.22	SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RCKT, RCOR, SMBC, TALO (PR Newswire)
28.10.22	SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates EQ, RCKT, RMED, RCOR (PR Newswire)
13.10.22	SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FORG, KNBE, AAWW, RCKT (PR Newswire)
06.10.22	SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates STOR, RCKT, RCOR, FCRD (PR Newswire)
04.10.22	Rocket Pharmaceuticals Adds 10%; Prices 6.8 Mln Share Offering (RTTNews)
04.10.22	Rocket Pharma Prices Public Offering Of 6.80 Mln Shares At $14.75/shr (RTTNews)
26.09.22	SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates EQ, MTCR, STOR, RCKT (PR Newswire)
20.09.22	SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RCKT, RCOR, EVOP, GMTX (PR Newswire)
20.09.22	Rocket Pharma To Buy Renovacor For $2.60/ Share In Stock (RTTNews)
16.08.21	Rocket Pharma Says FDA Lifts Clinical Hold On Phase 1 Trial Of RP-A501 For Danon Disease (RTTNews)
28.12.20	Biotech Stock Picks That Delivered Triple-digit Gains - Is There More Room To Run? (RTTNews)
10.12.20	GTHX Gains On Breast Cancer Trial Data, RCKT Soars On Danon Disease Study Results, XBIO Abuzz (RTTNews)
09.12.20	Pre-market Movers In Healthcare Sector: RCKT, LPCN, PRPH, KZIA, CRIS… (RTTNews)
07.12.20	Week Ahead In Pharma: FDA Decisions, ASH Data Readouts (LPCN, SYRS, MBIO, CYAD...) (RTTNews)
05.11.20	BIIB Faces FDA Panel Tomorrow, CRSP Climbs On Hemoglobinopathies Trial Data, SAVA On Watch (RTTNews)
03.09.20	AGTC Abuzz, AMRN Slumps & CORT Soars As Oral Arguments Commence, FLGT Gears Up, NNVC On Watch (RTTNews)
03.07.20	IMMU Continues Ascent, IDXG On Fire, REGN's Kevzara Disappoints In COVID-19 Trial, BLFS On Watch (RTTNews)
09.12.19	Stock To Watch: Rocket Pharma On Track (RTTNews)
05.06.18	DCPH Soars On ASCO Data, AVXL Braces For Busy Year, GHDX In Good Health (RTTNews)
12.05.18	An Ear To The Pharma: 8 Stocks To Watch (VYGR, BOLD, RXII, CYAD…) (RTTNews)
01.02.18	ZFGN Awaits Data, SLDB Makes Solid Gains, RCKT On Fire, SGEN Snaps Up CASC (RTTNews)
24.01.18	VTVT Up 30% In 5 Days, INO Gets Shot In The Arm, DRNA, HBIO On Fire (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’263.50	2.89 %	K V
Sonova Hldg	312.10	2.66 %	K V
Novartis	93.68	2.32 %	K V
Geberit	526.80	1.97 %	K V
Roche Hldg G	254.30	1.27 %	K V
Kuehne+Nagel Int	209.50	0.72 %	K V
UBS Group	28.30	0.57 %	K V
Givaudan	3’933.00	0.36 %	K V
Nestle	76.00	0.05 %	K V
Lonza Grp	521.40	-0.04 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Rocket Pharmaceuticals

Aktien Top/Flop

Rocket Pharmaceuticals Peer Group Nachrichten

Meistgelesene Nachrichten